H2O AM’s Vertex Pharmaceuticals VRTX Stock Holding History

H2O AM’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,290	Closed	-$783K	–	175
2020 Q1	$783K	Sell	3,290 -19,654	-86%	-$4.51M	0.62%	38
2019 Q4	$5.02M	Sell	22,944 -6,442	-22%	-$1.3M	1.19%	32
2019 Q3	$4.98M	Sell	29,386 -9,737	-25%	-$1.72M	0.85%	40
2019 Q2	$7.13M	Buy	39,123 +3,544	+10%	+$620K	0.6%	56
2019 Q1	$7.19M	Buy	35,579 +9,179	+35%	+$1.7M	0.9%	34
2018 Q4	$4.26M	Buy	+26,400	New	+$4.57M	0.47%	42

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

H2O AM's VRTX Position: Q2 2020 in Review

H2O AM sold out of Vertex Pharmaceuticals (VRTX) in Q2 2020, closing a stake of 3,290 shares — an estimated $783K sold.

H2O AM first reported a position in VRTX in Q4 2018 and held it in 6 quarters. The position peaked at $7.19M in Q1 2019. 964 funds tracked by Wall St. Rank hold VRTX as of Q2 2020.

H2O AM reported no remaining Vertex Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
H2O AM sold 3,290 Vertex Pharmaceuticals shares in Q2 2020, an estimated $783K.
H2O AM first reported a position in Vertex Pharmaceuticals in Q4 2018 and held it in 6 quarters.
H2O AM's Vertex Pharmaceuticals position peaked at $7.19M in Q1 2019.
964 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2020.

Based on H2O AM's 13F filing for Q2 2020, filed 13 Aug 2020.